The Ampli1™ OncoSeek Panel for Illumina® enables the preparation of high-quality targeted NGS libraries starting from whole genome amplified DNA obtained with Ampli1 WGA Kit.
It allows the simultaneous detection of single nucleotide variants (SNVs), insertions/deletions (indels) and copy-number amplifications (CNAs) in a panel of 60 clinically relevant oncology-related genes.
The Ampli1™ OncoSeek Panel works exclusively with Ampli1™ WGA product. The complete workflow takes advantage of the isolation of 100% pure cells with the DEPArray™ system and balanced whole genome amplification using the Ampli1™ WGA kit.
References
Maturo et al, Cancer Genomics 2019, "Development and Validation of Target Next-Generation Sequencing Panel for detection of somatic mutations and focal Copy Number Amplifications (CNAs) in single Circulating Tumor Cells (CTCs)"
Forcato et al, EACR-ESMO Liquid Biopsies 2019, "Comprehensive molecular profiling of single Circulating Tumor Cells (CTCs) reveals intra-patient heterogeneity"
Tononi et al, AACR 2019, "Validation of a targeted sequencing workflow for sequence variants and focal Copy Number Alterations (CNAs) in single Circulating Tumor Cells (CTCs)"
To download the posters please go to our Posters page.
To download Material Safety Data Sheets (MSDS), please click here.
The Ampli1™OncoSeek Panel is for Research Use Only. Not for use in diagnostic procedures.
